C-reactive protein decreases prostacyclin release from human aortic endothelial cells

Circulation

Volumn 108, Issue 14, 2003, Pages 1676-1678

  Venugopal, Kumar Senthil ^b   Devaraj, Sridvi ^b   Jialal, Ishwarlal ^a  

^a Laboratory for Atherosclerosis and Metabolic Research   (United States)

^b NONE

Author keywords

Atherosclerosis; Endothelium; Inflammation; Nitric oxide; Platelets

Indexed keywords

C REACTIVE PROTEIN; CALCIMYCIN; NITRIC OXIDE SYNTHASE; PEROXYNITRITE; PROSTACYCLIN; PROSTAGLANDIN F1 ALPHA; PROSTAGLANDIN SYNTHASE;

AORTA; ARTICLE; ATHEROGENESIS; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME ASSAY; HUMAN; HUMAN CELL; MEDIATOR RELEASE; NITRATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; THROMBOCYTE AGGREGATION INHIBITION; THROMBOGENESIS; VASCULAR ENDOTHELIUM; VASODILATATION;

AORTA; ASCORBIC ACID; C-REACTIVE PROTEIN; CELLS, CULTURED; CORONARY VESSELS; CYTOCHROME P-450 ENZYME SYSTEM; ENDOTHELIUM, VASCULAR; EPOPROSTENOL; FREE RADICAL SCAVENGERS; HUMANS; INTRAMOLECULAR OXIDOREDUCTASES; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PEROXYNITROUS ACID; PROSTAGLANDINS F; TYROSINE; URIC ACID;

EID: 0141885287     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000094736.10595.A1     Document Type: Article

References (18)

1. Yeh ET, Willerson JT. Coming of age of C-reactive protein: using inflammation markers in cardiology. Circulation. 2003;107:370-371.
2. Jialal I, Devaraj S. Inflammation and atherosclerosis: the value of the high-sensitivity C-reactive protein assay as a risk marker. Am J Clin Pathol. 2001;116:S108-S115.
3. Tomai F, Crea F, Gaspardone A, et al. Unstable angina and elevated C-reactive protein levels predict enhanced vasoreactivity of the culprit lesion. Circulation. 2001;104:1471-1476.
4. Cleland SJ, Sattar N, Petrie JR, et al. Endothelial dysfunction as a possible link between C-reactive protein levels and cardiovascular disease. Clin Sci (Lond). 2000;98:531-535.
5. Fichtlscherer S, Rosenberger G, Walter DH, et al. Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease. Circulation. 2000;102:1000-1006.
6. Venugopal SK, Devaraj S, Yuhanna I, et al. Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells. Circulation. 2002;106:1439-1441.
7. Smyth EM, Fitzgerald GA. Human prostacyclin receptor. Vitam Horm. 2002;65:149-165.
8. Todaka T, Yokoyama C, Yanamoto H, et al. Gene transfer of human prostacyclin synthase prevents neointimal formation after carotid balloon injury in rats. Stroke. 1999;30:419-426.
9. Zou MH, Leist M, Ullrich V. Selective nitration of prostacyclin synthase and defective vasorelaxation in atherosclerotic bovine coronary arteries. Am J Pathol. 1999;154:1359-1365.
10. Zou M, Jendral M, Ullrich V. Prostaglandin endoperoxide: dependent vasospasm in bovine coronary arteries after nitration of prostacyclin synthase. Br J Pharmacol. 1999;126:1283-1292.
11. Schmidt P, Youhnovski N, Daiber A, et al. Specific nitration at Tyr 430 revealed by high resolution mass spectrometry as basis for redox regulation of bovine prostacyclin synthase. J Biol Chem. 2003;278:12813-12819.
12. Devaraj S, Li D, Jialal I. The effects of alpha tocopherol supplementation on monocyte function: decreased lipid oxidation, interleukin 1 beta secretion, and monocyte adhesion to endothelium. J Clin Invest. 1996;98:756-763.
13. Halliwell B, Evans P, Whiteman M. Assessment of peroxynitrite scavengers in vitro. Methods Enzymol. 1999;301:333-342.
14. Moncada S, Vane JR. Pharmacology and endogenous roles of prostaglandin endoperoxides, thromboxane A2, and prostacyclin. Pharmacol Rev. 1978;30:293-331.
15. Sampson JB, Ye Y, Rosen H, et al. Myeloperoxidase and horseradish peroxidase catalyze tyrosine nitration in proteins from nitrite and hydrogen peroxide. Arch Biochem Biophys. 1998;356:207-213.
16. Devaraj S, Xu DY, Jialal I. C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells: implications for the metabolic syndrome and atherothrombosis. Circulation. 2003;107:398-404.
17. Cermak J, Key NS, Bach RR, et al. C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor. Blood. 1993;82:513-520.
18. Danenberg HD, Szalai AJ, Swaminathan RV, et al. Increased thrombosis after arterial injury in human C-reactive protein transgenic mice. Circulation. 2003;108:512-515.